The TSC2 gene helps keep cell growth under control, so tissues develop in an organized way. The protein made by this gene helps your cells respond to growth signals, and if it does not work properly, noncancerous growths can form in places such as the brain, skin, kidneys, heart, or lungs. A harmful variant in the TSC2 gene can cause tuberous sclerosis complex. Some people may have seizures, skin changes, learning or behavior differences, or kidney problems, although effects vary widely.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or to regulate processes in the body. Some genes hold the instructions for producing proteins, the parts of cells that do the work. Other genes are mainly involved in controlling when certain processes happen, where they happen, and how strongly they run. Together, genes influence how the body develops and functions, and they can shape how you respond to food, stress, or medications. To explore this topic in greater depth, you can learn more in the LearnHub.
Overview
TSC2Gene function
What if the gene works
The TSC2 gene helps control when cells grow, divide, and use energy. Working with the TSC1 gene, it acts like a brake on a key growth pathway, helping tissues develop in a balanced way.
Risk
What if the gene does not work
Pathogenic variants in the TSC2 gene can cause tuberous sclerosis complex, with noncancerous growths and variable effects including seizures, learning difficulties, and kidney or lung involvement. Milder and more severe variants can shape timing and severity.
Treatment
What does that mean for your treatment
Pathogenic variants in the TSC2 gene can make mTOR inhibitor treatment relevant. Drugs such as everolimus, and sometimes sirolimus, are used in guideline based care for selected brain or kidney growths and, in some people, seizures. These variants help explain why blocking the mTOR pathway can help, but treatment choice still depends on the specific health problem and its severity.
Conditions associated with TSC2
Gene function
What if the gene works
Your cells need clear stop and go signals so they grow only when conditions are right. The TSC2 gene helps manage those signals, especially those linked to energy, nutrients, and normal cell growth. Understanding what the TSC2 gene does in the body helps show how tissues stay balanced from day to day.
The TSC2 gene helps keep cell growth at an appropriate pace. Its protein works with the TSC1 gene's protein to quiet mTOR, a major growth signal, when conditions are not right for extra growth.
This gene helps cells respond to how much energy they have available. When energy is low, it slows growth activities so the cell can focus on essential work and stay in balance.
TSC2 helps control when cells make new proteins, which are the working parts of the cell. This supports routine maintenance and normal growth without using resources too quickly.
Cells use the TSC2 gene to combine messages about nutrients, energy, and outside growth cues. This lets a cell adjust its building activity to match current conditions.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. Variants are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many have no noticeable effect at all and simply represent the usual range of genetic differences between people. At times, though, a variant can change how a gene functions more significantly and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
This helps explain how variants in the TSC2 gene affect protein function: many changes shorten the tuberin protein, destabilize it, or weaken its link with the TSC1 protein, leaving mTOR signaling (a key growth control pathway) less controlled. Milder variants may leave some activity, while more severe variants can remove it almost completely. In tuberous sclerosis complex, variants that disrupt function more strongly are often linked to earlier or broader features, although the pattern can vary from person to person.
How variants are linked to conditions
Pathogenic variants in the TSC2 gene cause tuberous sclerosis complex, a condition that can affect the brain, skin, kidneys, heart, eyes, and lungs. In practice, this means TSC2 gene variants are linked to seizures, learning or behavior differences, benign growths in several organs, and lung disease called lymphangioleiomyomatosis in some women. A confirmed disease-causing TSC2 variant can establish the diagnosis, although symptoms and severity vary widely from person to person.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common across the general population. Most have no direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For TSC2, the main risk comes from having a disease-causing change in the gene itself, and this usually runs in families or starts as a new change at conception. Lifestyle habits are not known to meaningfully change the chance of having tuberous sclerosis, though symptoms can vary a lot from one person to another. Genetic counseling can help explain family risk.
Inheritance of TSC2 variants
For families trying to understand how TSC2 variants are inherited, the usual pattern is autosomal dominant. This means a parent with a disease-causing variant in the TSC2 gene has a 50% chance in each pregnancy of passing it on to a child, regardless of sex. Tuberous sclerosis complex can also happen because of a new (de novo) variant, meaning it appears for the first time in the child and was not inherited from either parent.
What does my TSC2 result mean for my family?
For TSC2, the main family pattern is dominant, which means a parent, brother, sister, or child may also carry the same gene change and may want to discuss testing. Each child of someone with a disease-causing TSC2 variant has a 1 in 2 chance of inheriting it. Some cases happen for the first time in one person, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for TSC2 variants usually uses a blood or saliva sample to read the TSC2 gene and look for changes linked with tuberous sclerosis complex. Results can help confirm the diagnosis, show whether a variant was inherited or arose for the first time, and guide family testing.
When should I consider getting a genetic test?
Consider testing for changes in the TSC2 gene if you or your child has signs of tuberous sclerosis complex, such as seizures, unusual light or raised skin patches, or noncancerous growths in the brain, kidneys, heart, or lungs. Testing can also help when this condition runs in the family.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it clarifies depends on the condition and on the specific type of variant. How the body functions over time is also shaped by many other factors, including lifestyle, environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information provides context rather than certainty and makes the most sense when viewed with the rest of a person’s care. In other situations, it may give a clear answer. In areas like medication response, genetic results can help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how a person responds to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This is common and helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics is the area of medicine that examines how genetic differences shape the way people respond to medications. It studies links between genes and drugs to help explain why the same treatment can affect one person differently than another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed and individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the TSC2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so concerns about treatment, side effects, or new symptoms are best discussed with your doctor. For TSC2, doctors may use the gene result as part of treatment planning in tuberous sclerosis, including whether medicines that calm an overactive cell-growth signal may help, but this is not the same as an established drug-response rule.
History
Tuberous sclerosis was first described in the late 1800s, long before doctors knew which genes were involved. Initially understood only through visible traits, later recognized as tied to a specific gene, the TSC2 gene became a major focus after researchers mapped it to chromosome 16 in the early 1990s. In 1993, scientists identified the TSC2 gene itself, a key step in explaining why some families had inherited forms of the condition. This discovery also helped clarify why tuberous sclerosis can vary so much from one person to another. From these first observations, research expanded steadily, and TSC2 became part of a broader shift toward gene-based diagnosis in neurology and inherited conditions.